Theodore P. Braun

2.8k total citations · 1 hit paper
45 papers, 1.5k citations indexed

About

Theodore P. Braun is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Theodore P. Braun has authored 45 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 18 papers in Hematology and 11 papers in Genetics. Recurrent topics in Theodore P. Braun's work include Acute Myeloid Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (8 papers) and Epigenetics and DNA Methylation (7 papers). Theodore P. Braun is often cited by papers focused on Acute Myeloid Leukemia Research (15 papers), Histone Deacetylase Inhibitors Research (8 papers) and Epigenetics and DNA Methylation (7 papers). Theodore P. Braun collaborates with scholars based in United States, Canada and Germany. Theodore P. Braun's co-authors include Daniel L. Marks, Brian Druker, Christopher A. Eide, Xinxia Zhu, Aaron J. Grossberg, Peter R. Levasseur, Marek Szumowski, Julia E. Maxson, A. K. Batra and Sambasivarao Damaraju and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Experimental Medicine and Journal of Neuroscience.

In The Last Decade

Theodore P. Braun

42 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Response and Resistance to BCR-ABL1-Targeted Therapies

2020 308 citations Theodore P. Braun, Christopher A. Eide et al. Cancer Cell profile →

Peers

Countries citing papers authored by Theodore P. Braun

Since Specialization

Citations

This map shows the geographic impact of Theodore P. Braun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Theodore P. Braun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Theodore P. Braun more than expected).

Fields of papers citing papers by Theodore P. Braun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Theodore P. Braun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Theodore P. Braun. The network helps show where Theodore P. Braun may publish in the future.

Co-authorship network of co-authors of Theodore P. Braun

This figure shows the co-authorship network connecting the top 25 collaborators of Theodore P. Braun. A scholar is included among the top collaborators of Theodore P. Braun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Theodore P. Braun. Theodore P. Braun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual ASXL1 and CSF3R mutations drive myeloid-biased stem cell expansion and enhance neutrophil differentiation 2025 ·Blood Advances ·(unknown), (unknown), TuDung T. Nguyen, Hans L. Carlson, (unknown), Sunil Shrestha, (unknown), (unknown), Sarah Taylor, Amy Foley, (unknown), Eric M. Pietras, Theodore P. Braun, Julia E. Maxson	0
2	CITEViz: interactively classify cell populations in CITE-Seq via a flow cytometry-like gating workflow using R-Shiny 2024 ·BMC Bioinformatics ·(unknown), (unknown), (unknown), (unknown), (unknown), Theresa A. Lusardi, (unknown), (unknown), (unknown), Theodore P. Braun, Julia E. Maxson	1
3	Influence of AML Differentiation State in Risk Stratification of Frontline Therapy with Hypomethylating Agents + Venetoclax in AML 2024 ·Blood ·Curtis A. Lachowiez, Joshua F. Zeidner, (unknown), D. Peters, (unknown), (unknown), Andy Kaempf, Fangyan Dai, Christopher A. Eide, Stephen E. Kurtz, Theodore P. Braun, Ronan Swords, Jennifer N. Saultz, Jeffrey Tyner, Daniel A. Pollyea	0
4	Predicting transcription factor activity using prior biological information 2024 ·iScience ·(unknown), Joseph Estabrook, (unknown), Julia Somers, Olga Nikolova, Özgün Babur, Theodore P. Braun, Emek Demir	1
5	Disruption of the MYC Superenhancer Complex by Dual Targeting of FLT3 and LSD1 in Acute Myeloid Leukemia 2023 ·Molecular Cancer Research ·(unknown), (unknown), Daniel J. Coleman, (unknown), (unknown), (unknown), Joseph Estabrook, Emek Demir, Nicola Long, Daniel Bottomly, Shannon K. McWeeney, Jeffrey Tyner, Brian Druker, Julia E. Maxson, Theodore P. Braun	5
6	Multicancer Early Detection Tests: An Overview of Early Results From Prospective Clinical Studies and Opportunities for Oncologists 2023 ·JCO Oncology Practice ·(unknown), Theodore P. Braun, Ruth Etzioni, Nima Nabavizadeh	6
7	Case Report: ASXL1, RUNX1, and IDH1 mutation in tyrosine kinase-independent resistant chronic myeloid leukemia progressing to chronic myelomonocytic leukemia-like accelerated phase 2023 ·Frontiers in Oncology ·(unknown), (unknown), Philipp W. Raess, Theodore P. Braun	1
8	Mutated SETBP1 activates transcription of Myc programs to accelerate CSF3R -driven myeloproliferative neoplasms 2022 ·Blood ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Brian Druker, Theodore P. Braun, Julia E. Maxson	9
9	GoPeaks: histone modification peak calling for CUT&Tag 2022 ·Genome biology ·(unknown), (unknown), (unknown), (unknown), Daniel J. Coleman, Lucia Carbone, Galip Gürkan Yardımcı, Julia E. Maxson, Theodore P. Braun	25
10	Outgrowth of a CSF3R-mutant clone drives a second myeloproliferative neoplasm in a chronic myeloid leukemia patient: a case report 2021 ·Biomarker Research ·(unknown), (unknown), Julia E. Maxson, Brian Druker, Theodore P. Braun	1
11	Navigating Challenges in Monitoring Chronic Myeloid Leukemia with Multiple BCR-ABL1 Transcripts 2021 ·Case Reports in Oncology ·(unknown), (unknown), Brian Druker, Theodore P. Braun	4
12	Response and Resistance to BCR-ABL1-Targeted Therapies breakdown → 2020 ·Cancer Cell ·Theodore P. Braun, Christopher A. Eide, Brian Druker	308
13	Muscle Atrophy in Response to Cytotoxic Chemotherapy Is Dependent on Intact Glucocorticoid Signaling in Skeletal Muscle 2014 ·PLoS ONE ·Theodore P. Braun, Marek Szumowski, Peter R. Levasseur, Aaron J. Grossberg, Xinxia Zhu, Anupriya Agarwal, Daniel L. Marks	72
14	Acute promyelocytic leukemia with JAK2 V617F and severe differentiation syndrome 2014 ·Leukemia Research Reports ·Theodore P. Braun, Julia E. Maxson, Anupriya Agarwal, (unknown), Stephen E. Spurgeon, Elie Traer	3
15	P‐selectin genotype is associated with the development of cancer cachexia 2012 ·EMBO Molecular Medicine ·Benjamin Tan, Torill Fladvad, Theodore P. Braun, Antonio Viganò, Florian Strasser, D A C Deans, Richard J. E. Skipworth, Tora S. Solheim, Sambasivarao Damaraju, James A. Ross, Stein Kaasa, Daniel L. Marks, Vickie E. Baracos, Frank Skorpen, Kenneth C. H. Fearon	37
16	Inflammation-Induced Lethargy Is Mediated by Suppression of Orexin Neuron Activity 2011 ·Journal of Neuroscience ·Aaron J. Grossberg, Xinxia Zhu, Gina M. Leinninger, Peter R. Levasseur, Theodore P. Braun, Martin G. Myers, Daniel L. Marks	108
17	Hypothalamic regulation of muscle metabolism 2011 ·Current Opinion in Clinical Nutrition & Metabolic Care ·Theodore P. Braun, Daniel L. Marks	12
18	Maternal High Fat Diet Is Associated with Decreased Plasma n–3 Fatty Acids and Fetal Hepatic Apoptosis in Nonhuman Primates 2011 ·PLoS ONE ·Wilmon F. Grant, Melanie B. Gillingham, A. K. Batra, Natasha M. Fewkes, Sarah Comstock, Diana Takahashi, Theodore P. Braun, Kevin L. Grove, Jacob E. Friedman, Daniel L. Marks	79
19	Progéniteurs endothéliaux circulants: nouveaux biomarqueurs et thérapeutique du futur en réanimation 2007 ·Médecine et Maladies Infectieuses ·Thierry Seguin, Theodore P. Braun, Jean‐Paul Mira	2
20	Selective killing of the human malaria parasite Plasmodium falciparum by a benzylthiazolium dye 2006 ·Experimental Parasitology ·Jane X. Kelly, Rolf W. Winter, Theodore P. Braun, (unknown), David J. Hinrichs, Michael K. Riscoe	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact